Anita Shirwaiker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anita Shirwaiker has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Peter Merrick Kistler
The Alfred Hospital, Melbourne, Australia; The Baker Heart and Diabetes Research Institute, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Monash University, Melbourne, Australia; Cabrini Malvern Hospital, Melbourne, Australia
5 shared publications - Aleksandr Voskoboinik
The Alfred Hospital Melbourne Australia
4 shared publications Ian Hong Siang Goh
University Hospital Geelong Barwon Health Geelong Victoria Australia
2 shared publicationsLuke Kristofer Cieslik
University Hospital Geelong Barwon Health Geelong Victoria Australia
2 shared publicationsA Voskoboinik
The Alfred Hospital, Heart Centre, Melbourne, Australia
1 shared publicationAlan Appelbe
University Hospital Geelong Barwon Health Geelong Victoria Australia
1 shared publication
Latest Publications
- 30 August 2023
- Published by Wiley in Echocardiography
- Vol. 40 (10) , 1137-1139
Left atrial mitral valve chordae: An important congenital abnormality mimicking endocarditis on transthoracic echocardiography—Case report
A 59‐year‐old male was incidentally diagnosed with a left atrial mitral valve chordae involving the junction of the A1 and A2 mitral valve leaflets and resulting in moderate mitral regurgitation. The recognition of this extremely rare congenital malformation prevented over diagnosis and overtreatment.
- 30 August 2023
- Published by Wiley in Echocardiography
- Vol. 40 (10) , 1137-1139
Left atrial mitral valve chordae: An important congenital abnormality mimicking endocarditis on transthoracic echocardiography—Case report
A 59‐year‐old male was incidentally diagnosed with a left atrial mitral valve chordae involving the junction of the A1 and A2 mitral valve leaflets and resulting in moderate mitral regurgitation. The recognition of this extremely rare congenital malformation prevented over diagnosis and overtreatment.
- Open Access
- 24 June 2023
- Published by Wiley
Left atrial mitral valve chordae; an important congenital abnormality mimicking endocarditis on transthoracic echocardiography
A 59-year-old male was incidentally diagnosed with a left atrial mitral valve chordae involving the junction of the A1 and A2 mitral valve leaflets and resulting in moderate mitral regurgitation. The recognition of this extremely rare congenital malformation prevented over diagnosis and overtreatment.
- 24 June 2023
- Published by Wiley
Open AccessLeft atrial mitral valve chordae; an important congenital abnormality mimicking endocarditis on transthoracic echocardiography
A 59-year-old male was incidentally diagnosed with a left atrial mitral valve chordae involving the junction of the A1 and A2 mitral valve leaflets and resulting in moderate mitral regurgitation. The recognition of this extremely rare congenital malformation prevented over diagnosis and overtreatment.
- Open Access
- 20 June 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (12) , e029259
Identifying Patients at High Risk of Left Atrial Appendage Thrombus Before Cardioversion: The CLOTS‐AF Score
Background: Transesophageal echocardiography–guided direct cardioversion is recommended in patients who are inadequately anticoagulated due to perceived risk of left atrial appendage thrombus (LAAT); however, LAAT risk factors remain poorly defined. Methods and Results: We evaluated clinical and transthoracic echocardiographic parameters to predict LAAT risk in consecutive patients with atrial fibrillation (AF)/atrial flutter undergoing transesophageal echocardiography before cardioversion between 2002 and 2022. Regression analysis identified predictors of LAAT, combined to create the novel CLOTS‐AF risk score (comprising clinical and echocardiographic LAAT predictors), which was developed in the derivation cohort (70%) and validated in the remaining 30%. A total of 1001 patients (mean age, 62±13 years; 25% women; left ventricular ejection fraction, 49.8±14%) underwent transesophageal echocardiography, with LAAT identified in 140 of 1001 patients (14%) and dense spontaneous echo contrast precluding cardioversion in a further 75 patients (7.5%). AF duration, AF rhythm, creatinine, stroke, diabetes, and echocardiographic parameters were univariate LAAT predictors; age, female sex, body mass index, anticoagulant type, and duration were not (all P >0.05). CHADS 2 VASc, though significant on univariate analysis ( P 1.5 mg/dL, Left ventricular ejection fraction 34 mL/m 2 ), Tricuspid Annular Plane Systolic Excursion (TAPSE) <17 mm, Stroke, and AF rhythm). The unweighted risk model had excellent predictive performance with an area under the curve of 0.820 (95% CI, 0.752–0.887). The weighted CLOTS‐AF risk score maintained good predictive performance (AUC, 0.780) with an accuracy of 72%. Conclusions: The incidence of LAAT or dense spontaneous echo contrast precluding cardioversion in patients with AF who are inadequately anticoagulated is 21%. Clinical and noninvasive echocardiographic parameters may identify patients at increased risk of LAAT better managed with a suitable period of anticoagulation before undertaking cardioversion.
- 20 June 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (12) , e029259
Open AccessIdentifying Patients at High Risk of Left Atrial Appendage Thrombus Before Cardioversion: The CLOTS‐AF Score
Background: Transesophageal echocardiography–guided direct cardioversion is recommended in patients who are inadequately anticoagulated due to perceived risk of left atrial appendage thrombus (LAAT); however, LAAT risk factors remain poorly defined. Methods and Results: We evaluated clinical and transthoracic echocardiographic parameters to predict LAAT risk in consecutive patients with atrial fibrillation (AF)/atrial flutter undergoing transesophageal echocardiography before cardioversion between 2002 and 2022. Regression analysis identified predictors of LAAT, combined to create the novel CLOTS‐AF risk score (comprising clinical and echocardiographic LAAT predictors), which was developed in the derivation cohort (70%) and validated in the remaining 30%. A total of 1001 patients (mean age, 62±13 years; 25% women; left ventricular ejection fraction, 49.8±14%) underwent transesophageal echocardiography, with LAAT identified in 140 of 1001 patients (14%) and dense spontaneous echo contrast precluding cardioversion in a further 75 patients (7.5%). AF duration, AF rhythm, creatinine, stroke, diabetes, and echocardiographic parameters were univariate LAAT predictors; age, female sex, body mass index, anticoagulant type, and duration were not (all P >0.05). CHADS 2 VASc, though significant on univariate analysis ( P 1.5 mg/dL, Left ventricular ejection fraction 34 mL/m 2 ), Tricuspid Annular Plane Systolic Excursion (TAPSE) <17 mm, Stroke, and AF rhythm). The unweighted risk model had excellent predictive performance with an area under the curve of 0.820 (95% CI, 0.752–0.887). The weighted CLOTS‐AF risk score maintained good predictive performance (AUC, 0.780) with an accuracy of 72%. Conclusions: The incidence of LAAT or dense spontaneous echo contrast precluding cardioversion in patients with AF who are inadequately anticoagulated is 21%. Clinical and noninvasive echocardiographic parameters may identify patients at increased risk of LAAT better managed with a suitable period of anticoagulation before undertaking cardioversion.
- Open Access
- 28 November 2022
- Published by Wiley
Diagnostic evaluation of unexplained ventricular tachyarrhythmias in younger adults
Background: The diagnostic work-up for cardiac arrest from ventricular tachyarrhythmias occurring in younger adults and structurally normal hearts is variable and often incomplete. Methods: We reviewed records for all recipients of a secondary prevention implantable cardiac defibrillator (ICD) younger than 60 years at a single quaternary referral hospital from 2010-2021. Patients were included if they had unexplained ventricular arrhythmias (UVA) and absence of structural heart disease on echocardiogram, normal coronary assessment and no clear diagnostic features on ECG. We specifically evaluated the adoption rate of five modalities of ‘second-line’ cardiac investigations: cardiac magnetic resonance imaging (CMR), exercise ECG, flecainide challenge, electrophysiology study (EPS) and genetic testing. We also evaluated patterns of anti-arrhythmic drug therapy and device-detected arrhythmias and compared them with secondary prevention ICD recipients with a clear aetiology found on initial assessment. Results: 102 recipients of a secondary prevention ICD under the age of 60 were analysed. 39 patients (38.2%) were identified with UVA and were compared with the remaining 63 patients with VA of clear aetiology (61.8%). UVA patients were younger (35.6 ± 13.0 years vs 46.0 ± 8.6 years, pConclusion: In this real-world analysis of patients with UVA, the diagnostic work-up is often incomplete. While CMR was increasingly utilized at our institution, investigations for channelopathies and genetic causes appear to be underutilized. Implementation of a systematic protocol for work-up of these patients requires further study.
- 28 November 2022
- Published by Wiley
Open AccessDiagnostic evaluation of unexplained ventricular tachyarrhythmias in younger adults
Background: The diagnostic work-up for cardiac arrest from ventricular tachyarrhythmias occurring in younger adults and structurally normal hearts is variable and often incomplete. Methods: We reviewed records for all recipients of a secondary prevention implantable cardiac defibrillator (ICD) younger than 60 years at a single quaternary referral hospital from 2010-2021. Patients were included if they had unexplained ventricular arrhythmias (UVA) and absence of structural heart disease on echocardiogram, normal coronary assessment and no clear diagnostic features on ECG. We specifically evaluated the adoption rate of five modalities of ‘second-line’ cardiac investigations: cardiac magnetic resonance imaging (CMR), exercise ECG, flecainide challenge, electrophysiology study (EPS) and genetic testing. We also evaluated patterns of anti-arrhythmic drug therapy and device-detected arrhythmias and compared them with secondary prevention ICD recipients with a clear aetiology found on initial assessment. Results: 102 recipients of a secondary prevention ICD under the age of 60 were analysed. 39 patients (38.2%) were identified with UVA and were compared with the remaining 63 patients with VA of clear aetiology (61.8%). UVA patients were younger (35.6 ± 13.0 years vs 46.0 ± 8.6 years, pConclusion: In this real-world analysis of patients with UVA, the diagnostic work-up is often incomplete. While CMR was increasingly utilized at our institution, investigations for channelopathies and genetic causes appear to be underutilized. Implementation of a systematic protocol for work-up of these patients requires further study.
- 28 April 2022
- Published by Elsevier in Heart Rhythm
- Vol. 19 (5) , S265
PO-655-06 PREDICTORS OF LATE ATRIAL FIBRILLATION RECURRENCE FOLLOWING CARDIAC SURGERY
- 28 April 2022
- Published by Elsevier in Heart Rhythm
- Vol. 19 (5) , S265
PO-655-06 PREDICTORS OF LATE ATRIAL FIBRILLATION RECURRENCE FOLLOWING CARDIAC SURGERY
- 23 February 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 31 (7) , 993-998
Long-Term Implications of Pacemaker Insertion in Younger Adults: A Single Centre Experience
- 23 February 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 31 (7) , 993-998
Long-Term Implications of Pacemaker Insertion in Younger Adults: A Single Centre Experience
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Long-term implications of pacemaker insertion in younger adults: a single centre experience
Background: The long-term implications of pacemaker insertion in younger adults are poorly described in the literature. Methods: We performed a retrospective analysis of consecutive younger adult patients (18–50 years) undergoing pacemaker implantation at a quaternary hospital between 1986–2020. Defibrillators and cardiac resynchronisation therapy devices were excluded. All clinical records, pacemaker checks and echocardiograms were reviewed. Results: 81 patients (39.5±9.6 years, 53% male) underwent pacemaker implantation. Indications were complete heart block (41%), sinus node dysfunction (33%), high grade AV block (11%) and tachycardia-bradycardia syndrome (7%). During a median 7.6 (IQR=0.6–14.8) years follow-up, 9 patients (11%) developed 13 late device-related complications (generator or lead malfunction requiring reoperation (n=11), device infection (n=1) and pocket revision (n=1)). Five of these patients were 10%) was observed in 14 patients (17%) and 7 of these patients required subsequent biventricular upgrade. Furthermore, 4 patients (5%) developed new tricuspid regurgitation (≥ moderate-severe). Of 69 patients with available long-term pacing data, minimal pacemaker utilisation (pacing <5% at all checks) was observed in 13 (19%) patients. Conclusions: Pacemaker insertion in younger adults has significant long-term implications. Clinicians should carefully consider pacemaker insertion in this cohort given risk of device-related complications, potential for device under-utilisation and issues related to lead longevity. In addition, patients require close follow-up for development of structural abnormalities and arrhythmias. Funding Acknowledgement: Type of funding sources: None.
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Long-term implications of pacemaker insertion in younger adults: a single centre experience
Background: The long-term implications of pacemaker insertion in younger adults are poorly described in the literature. Methods: We performed a retrospective analysis of consecutive younger adult patients (18–50 years) undergoing pacemaker implantation at a quaternary hospital between 1986–2020. Defibrillators and cardiac resynchronisation therapy devices were excluded. All clinical records, pacemaker checks and echocardiograms were reviewed. Results: 81 patients (39.5±9.6 years, 53% male) underwent pacemaker implantation. Indications were complete heart block (41%), sinus node dysfunction (33%), high grade AV block (11%) and tachycardia-bradycardia syndrome (7%). During a median 7.6 (IQR=0.6–14.8) years follow-up, 9 patients (11%) developed 13 late device-related complications (generator or lead malfunction requiring reoperation (n=11), device infection (n=1) and pocket revision (n=1)). Five of these patients were 10%) was observed in 14 patients (17%) and 7 of these patients required subsequent biventricular upgrade. Furthermore, 4 patients (5%) developed new tricuspid regurgitation (≥ moderate-severe). Of 69 patients with available long-term pacing data, minimal pacemaker utilisation (pacing <5% at all checks) was observed in 13 (19%) patients. Conclusions: Pacemaker insertion in younger adults has significant long-term implications. Clinicians should carefully consider pacemaker insertion in this cohort given risk of device-related complications, potential for device under-utilisation and issues related to lead longevity. In addition, patients require close follow-up for development of structural abnormalities and arrhythmias. Funding Acknowledgement: Type of funding sources: None.